戻る Agenda
Demystifying Technology Selection in Mobile Clinical Trials
Session Chair(s)
Thomas Switzer, MED
Principal Digital Health Scientist
Genentech, A Member of the Roche Group, United States
This session will describe CTTI resources that support the adoption of mobile technologies into clinical research by 1) eliminating redundant feasibility testing, and 2) promoting streamlined, informative studies where there are knowledge gaps.
Learning Objective : Describe how feasibility testing can reduce the risk of conducting mobile clinical trials; Identify how to initiate their own feasibility studies, where appropriate; Describe how to access and utilize the consortium's database of feasibility studies available as a resource summarizing current knowledge.
Speaker(s)
FDA Perspective
Isaac R Rodriguez-Chavez, MHS, PHD, MS
4Biosolutions Consulting, United States
Industry Update
Barry Peterson, PHD
Independent Consultant, United States
Wearable Devices
Panelist
Aaron Coleman
Fitabase, United States
Founder and Chief Executive Officer